ENS 56619: Difference between revisions

From kanterella
Jump to navigation Jump to search
(StriderTol Bot insert)
 
(StriderTol Bot change)
 
Line 20: Line 20:
On July 11, 2023, at 1700 EDT, an intravascular brachytherapy treatment was delivered to the wrong treatment site. The original dose of 23 Gy was intended for a different part of the vasculature system. The brachytherapy device made by Best Vascular is a Beta-Catch (model # 5ICW-2) containing 3.62 GBq of Sr/Y-90. Physicians expect that there will be no permanent damage to any of the patient's organs.
On July 11, 2023, at 1700 EDT, an intravascular brachytherapy treatment was delivered to the wrong treatment site. The original dose of 23 Gy was intended for a different part of the vasculature system. The brachytherapy device made by Best Vascular is a Beta-Catch (model # 5ICW-2) containing 3.62 GBq of Sr/Y-90. Physicians expect that there will be no permanent damage to any of the patient's organs.
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.
| URL = https://www.nrc.gov/reading-rm/doc-collections/event-status/event/2023/20230719en.html#en56619
| URL = https://www.nrc.gov/reading-rm/doc-collections/event-status/event/2023/20230720en.html#en56619
}}
}}


{{ENS-Nav}}
{{ENS-Nav}}

Latest revision as of 06:30, 20 July 2023

ENS 56619 +/-
Where
Henry Ford Hospital
Detroit, Michigan (NRC Region 3)
License number: 21-04109-16
Organization: Henry Ford Hospital
Reporting
10 CFR 35.3045(a)(2)
Time - Person (Reporting Time:+15.22 h0.634 days <br />0.0906 weeks <br />0.0208 months <br />)
Opened: Alan Jackson
12:13 Jul 12, 2023
NRC Officer: Ian Howard
Last Updated: Jul 12, 2023
56619 - NRC Website